Literature DB >> 18564729

Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis.

Soraya C Trindade1, Isaac S Gomes-Filho, Roberto J Meyer, Vera C Vale, Lívia Pugliese, Songelí M Freire.   

Abstract

UNLABELLED: Periodontitis is an inflammatory oral disease caused by multifactorial intrinsic and extrinsic agents, including Gram-negative bacteria such as Porphyromonas gingivalis.
OBJECTIVE: To evaluate if there is difference in the serum levels of IgA, IgG and IgG subclasses reactive to Porphyromonas gingivalis in subjects with different periodontal conditions.
METHODS: The study included 89 patients divided into four groups: 29 subjects with moderate or severe chronic periodontitis (CP), 12 with aggressive periodontitis (AP), 22 with gingivitis or mild periodontitis (GP), and 26 healthy controls (HC). Humoral response was assayed by enzyme-linked immunosorbent assay (ELISA) to verify serum levels of IgG, IgG1, IgG2, IgG3, IgG4 and IgA serum levels reacting to crude P. gingivalis ATCC 33277 sonicate extract and fraction IV, an enrichment of the immunoreactive bands of the crude extract obtained by chromatography.
RESULTS: IgA, IgG (p < 0.01), IgG2, IgG3 and IgG4 serum level reactions to fraction IV were higher in the CP group compared with the healthy control. The CP group had higher levels of IgG and IgG4 to both antigens than the GP group, and higher levels of IgG and IgG4 to sonicate extract than the AP group. There were statistically significant differences in serum levels of IgG to both antigens (p < 0.01), IgG2 to fraction IV (p < 0.01), IgG3 to fraction IV (p < 0.05) and IgG4 to both antigens (p < 0.05) between AP and HC groups. IgG1 titers to sonicate extract were significantly higher (p < 0.05) in the GP group in comparison to the AP group.
CONCLUSIONS: The findings of this study suggest that there are differences in the serum levels of IgA, IgG and IgG subclasses in patients with different periodontal conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564729

Source DB:  PubMed          Journal:  J Int Acad Periodontol        ISSN: 1466-2094


  4 in total

1.  Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.

Authors:  Ted R Mikuls; Jeffrey B Payne; Richard A Reinhardt; Geoffrey M Thiele; Eileen Maziarz; Amy C Cannella; V Michael Holers; Kristine A Kuhn; James R O'Dell
Journal:  Int Immunopharmacol       Date:  2008-10-09       Impact factor: 4.932

2.  Porphyromonas gingivalis HmuY stimulates expression of Bcl-2 and Fas by human CD3+ T cells.

Authors:  Paulo C Carvalho-Filho; Soraya C Trindade; Teresa Olczak; Geraldo P Sampaio; Milton G Oliveira-Neto; Heidiane A Santos; Bianca F P Pereira; Lilia Moura-Costa; Márcia T Xavier; Roberto Meyer
Journal:  BMC Microbiol       Date:  2013-09-11       Impact factor: 3.605

3.  In silico analysis as a strategy to identify candidate epitopes with human IgG reactivity to study Porphyromonas gingivalis virulence factors.

Authors:  Ellen Karla Nobre Dos Santos-Lima; Kizzes Araújo Paiva Andrade Cardoso; Patrícia Mares de Miranda; Ana Carla Montino Pimentel; Paulo Cirino de Carvalho-Filho; Yuri Andrade de Oliveira; Lília Ferreira de Moura-Costa; Teresa Olczak; Isaac Suzart Gomes-Filho; Roberto José Meyer; Márcia Tosta Xavier; Soraya Castro Trindade
Journal:  AMB Express       Date:  2019-03-11       Impact factor: 3.298

4.  A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes.

Authors:  Hong Jiang; Xu Xiong; Yi Su; Yiming Zhang; Hongqiao Wu; Zhijun Jiang; Xu Qian
Journal:  BMC Pregnancy Childbirth       Date:  2013-12-09       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.